Lineage Cell Therapeutics
LCTX
$1.09
Share price
-3.54%
Change (1 day)
-16.79%
Change (1 year)
Categories
EPS for Lineage Cell Therapeutics (LCTX)
EPS in 2023 (TTM): -$0.13
According to Lineage Cell Therapeutics 's latest financial reports the company's current EPS (TTM) is -$0.13. In 2022 the company made an earnings per share (EPS) of -$0.15 an increase over its 2021 EPS that were of -$0.26.
EPS history for Lineage Cell Therapeutics from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.13 | -13.33% |
| 2022 | -$0.15 | -42.31% |
| 2021 | -$0.26 | 85.71% |
| 2020 | -$0.14 | 250% |
| 2019 | -$0.04000 | -88.57% |
| 2018 | -$0.35 | 105.88% |
| 2017 | -$0.17 | -153.13% |
| 2016 | $0.32 | -154.24% |
| 2015 | -$0.59 | 5.36% |
| 2014 | -$0.56 | -30.86% |
| 2013 | -$0.81 | 88.37% |
| 2012 | -$0.43 | 19.44% |
| 2011 | -$0.36 | 33.33% |
| 2010 | -$0.27 | 68.75% |
| 2009 | -$0.16 | -5.88% |
| 2008 | -$0.17 | 183.33% |
| 2007 | -$0.06000 | -25% |
| 2006 | -$0.08000 | -27.27% |
| 2005 | -$0.11 | -38.89% |
| 2004 | -$0.18 | 38.46% |
| 2003 | -$0.13 | -43.48% |
| 2002 | -$0.23 | -26.63% |
| 2001 | -$0.31 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 1,576.92% | 🇺🇸 USA |